title: [Heparin-like anticoagulant in small cell bronchial carcinoma].
abstract: Acquired circulating heparin-like anticoagulants may have different causes, the most frequent being plasmocyte proliferation. The authors report an exceptional case of association between an heparin-like inhibitor and a small-cell anaplastic lung carcinoma, and they review the pathogenesis, laboratory diagnostic methods and treatment of the anticoagulant.
authors.affiliation: Service de Médecine Interne I, Hôpital de Cimiez, Nice.
authors.forename: G
authors.initials: G
authors.lastname: Garnier
authors.forename: B
authors.initials: B
authors.lastname: Taillan
authors.forename: J
authors.initials: J
authors.lastname: Castanet
authors.forename: A
authors.initials: A
authors.lastname: Pesce
authors.forename: P
authors.initials: P
authors.lastname: Dujardin
mesh_terms: D018288:Carcinoma, Small Cell / Q000097:blood*; D006493:Heparin; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis*; D008175:Lung Neoplasms / Q000097:blood*; D008297:Male; D008875:Middle Aged; D013921:Thrombocytopenia / Q000209:etiology
chemical_list: D007136:Immunoglobulins; C019158:circulating anticoagulants; D006493:Heparin
vernacular_title: Anticoagulant circulant "heparine like" au cours d'un carcinome bronchique à petites cellules.